Invention Grant
- Patent Title: SEMA4D in cancer diagnosis, detection and treatment
- Patent Title (中): SEMA4D在癌症诊断，检测和治疗中的应用
-
Application No.: US11918179Application Date: 2006-04-07
-
Publication No.: US07919246B2Publication Date: 2011-04-05
- Inventor: Albert Lai , Abdallah Fanidi , Robert Booher , Christin Tse , Xie Xu , Guoying Yu , Edward Moler , Michael Rowe
- Applicant: Albert Lai , Abdallah Fanidi , Robert Booher , Christin Tse , Xie Xu , Guoying Yu , Edward Moler , Michael Rowe
- Applicant Address: US CA Emeryville US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.,Sagres Discovery, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.,Sagres Discovery, Inc.
- Current Assignee Address: US CA Emeryville US CA Emeryville
- Agent David A. Carpenter
- International Application: PCT/US2006/013174 WO 20060407
- International Announcement: WO2006/110594 WO 20061019
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/53
Abstract:
This invention is in the field of cancer-related genes. Specifically it relates to methods for detecting cancer or the likelihood of developing cancer based on the presence or absence of the SEM A4D gene or proteins encoded by this gene. The invention also provides methods and molecules for upregulating or downregulating the SEMA4D gene.
Public/Granted literature
- US20090104193A1 SEMA4D in Cancer Diagnosis, Detection and Treatment Public/Granted day:2009-04-23
Information query
